Home › NDC Lookup › RxCUI directory › RxCUI 1743833

2 ML famotidine 10 MG/ML Injection — RxCUI 1743833

RxNorm drug concept · Semantic clinical drug
RxCUI 1743833 Semantic clinical drug · SCD ● Current RxNorm concept 15 FDA products 18 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1743833
Official name2 ML famotidine 10 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asfamotidine 20 MG per 2 ML Injection; famotidine 20 MG in 2 ML Injection
FDA products mapped15
Package NDCs mapped18
Reported Medicaid activity (SDUD)120,313 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Famotidine Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Famotidine injection is specifically for people in the hospital who can't swallow pills right now — maybe because of surgery, a procedure, or another medical reason. It delivers th...
  • Why am I getting famotidine through an IV instead of just taking a pill?
  • Because it goes straight into your vein, it works fast. The maximum acid-reducing effect kicks in within about 30 minutes of the infusion, and that effect can last 10 to 12 hours....
  • How quickly will famotidine injection start working?
📖 Read our full Famotidine Injection guide →

🕸️ Concept Web — How 2 ML famotidine 10 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 2 ML famotidine 10 MG/ML Injection RxCUI 1743833

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Famotidine 4278
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Famotidine Injection 1743827
    • Famotidine Injectable Product 1159019
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Famotidine 10 MG/ML 315920

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Famotidine 10 MG/ML SCDC · 315920
  • Famotidine Injection SCDF · 1743827
  • Famotidine Injectable Product SCDG · 1159019

📦 FDA Products & Package NDCs

15 products · 18 package NDCs
18 package NDCs map to RxCUI 1743833 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00641-6021-10 10 VIAL in 1 CARTON (0641-6021-10) / 20 mL in 1 VIAL (0641-... Famotidine Hikma Pharmaceuticals USA Inc. 2001-04-16
00641-6022-25 25 VIAL in 1 CARTON (0641-6022-25) / 2 mL in 1 VIAL (0641-6... Famotidine Hikma Pharmaceuticals USA Inc. 2001-04-16
00641-6023-10 10 VIAL in 1 CARTON (0641-6023-10) / 4 mL in 1 VIAL (0641-6... Famotidine Hikma Pharmaceuticals USA Inc. 2023-05-16
00641-6023-25 25 VIAL in 1 CARTON (0641-6023-25) / 4 mL in 1 VIAL (0641-6... Famotidine Hikma Pharmaceuticals USA Inc. 2001-04-16
25021-0753-02 25 VIAL in 1 CARTON (25021-753-02) / 2 mL in 1 VIAL Famotidine Sagent Pharmaceuticals 2024-12-15
25021-0754-04 10 VIAL in 1 CARTON (25021-754-04) / 4 mL in 1 VIAL Famotidine Sagent Pharmaceuticals 2024-12-15
25021-0754-20 10 VIAL in 1 CARTON (25021-754-20) / 20 mL in 1 VIAL Famotidine Sagent Pharmaceuticals 2024-12-15
51662-1375-01 2 mL in 1 VIAL, SINGLE-DOSE (51662-1375-1) FAMOTIDINE HF Acquisition Co LLC, DBA HealthFirst 2019-12-09
51662-1375-02 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1375-2) / 2 mL in 1 V... FAMOTIDINE HF Acquisition Co LLC, DBA HealthFirst 2022-10-01
63323-0739-12 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-739-12) / 2 mL in 1 V... Famotidine Fresenius Kabi USA, LLC 2001-03-15
63323-0739-16 25 VIAL, SINGLE-USE in 1 TRAY (63323-739-16) / 2 mL in 1 VI... Famotidine Fresenius Kabi USA, LLC 2001-03-15
67457-0433-22 25 VIAL in 1 CARTON (67457-433-22) / 2 mL in 1 VIAL (67457-... Famotidine Mylan Institutional LLC 2008-06-26
67457-0448-43 10 VIAL in 1 CARTON (67457-448-43) / 4 mL in 1 VIAL (67457-... Famotidine Mylan Institutional LLC 2008-06-26
67457-0457-20 10 VIAL in 1 CARTON (67457-457-20) / 20 mL in 1 VIAL (67457... Famotidine Mylan Institutional LLC 2008-06-26
70860-0751-02 25 VIAL, SINGLE-DOSE in 1 CARTON (70860-751-02) / 2 mL in 1... Famotidine Athenex Pharmaceutical Division, LLC. 2020-08-10
71872-7220-01 1 VIAL in 1 BAG (71872-7220-1) / 2 mL in 1 VIAL Famotidine Medical Purchasing Solutions, LLC 2020-11-12
71872-7235-01 1 VIAL in 1 BAG (71872-7235-1) / 2 mL in 1 VIAL Famotidine Medical Purchasing Solutions, LLC 2020-12-15
71872-7366-01 1 VIAL in 1 BAG (71872-7366-1) / 2 mL in 1 VIAL Famotidine Medical Purchasing Solutions, LLC 2026-02-20
Observed labelers: Hikma Pharmaceuticals USA Inc. (4) · Medical Purchasing Solutions, LLC (3) · Mylan Institutional LLC (3) · Sagent Pharmaceuticals (3) · Fresenius Kabi USA, LLC (2) · HF Acquisition Co LLC, DBA HealthFirst (2) · +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J1308 Inj, famotidine, 0.25 mg 12 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.